earningsconfidence high
Health Catalyst Q1 revenue falls 11% YoY; net loss widens to $111M
Health Catalyst, Inc.
2026-Q1 EPS
reported -$1.53
vs consensus $0.02
▼ miss
(-8842.9%)
- Total revenue $70.8M vs $79.4M in Q1 2025; gross margin improved to 39% from 36%.
- Net loss of $111.0M, a 368% increase year-over-year from $23.7M loss in prior-year period.
- CEO Ben Albert says Q1 results exceeded expectations on revenue and adjusted EBITDA.
- Company announces strategic reset to focus on highest-conviction technology opportunities.
- Ticker: HCAT; Nasdaq-listed.
item 2.02item 9.01
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.